Neuromuscular Research Center

Phoenix, Arizona 85028

2 studies enrolling now · 16 studies all time

What they study most

ALS, Active Idiopathic Inflammatory Myopathy, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Antisynthetase Syndrome, Dermatomyositis, Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy (DMD), Generalized Myasthenia Gravis, Immune-Mediated Necrotizing Myopathy, Inclusion Body Myositis, Inclusion Body Myositis (IBM)

Studies at this site

• A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis — Recruiting now
• A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] — Recruiting now
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• Safety Study of Oral Edaravone Administered in Subjects With ALS — Completed
• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — Completed
• Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
• Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis — Running, not enrolling
• Study of M5049 in DM and PM Participants (NEPTUNIA) — Stopped early
• Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) — Running, not enrolling
• An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy — Stopped early
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• Study of Eteplirsen in DMD Patients — Completed
• Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy — Completed
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early